The human 2'-5'oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2'-5' instead of 3'-5' phosphodiester bond formation.
about
Activation of 2' 5'-oligoadenylate synthetase by stem loops at the 5'-end of the West Nile virus genomeBroad-spectrum antiviral therapeuticsViral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral responseThe Roles of RNase-L in Antimicrobial Immunity and the Cytoskeleton-Associated Innate ResponseImpact of allele-specific peptides in proteome quantificationInterplay between interferon-mediated innate immunity and porcine reproductive and respiratory syndrome virusInterferon-inducible antiviral effectorsGenetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in ManLong-Term Balancing Selection at the West Nile Virus Resistance Gene, Oas1b, Maintains Transspecific Polymorphisms in the House MouseCrystal structure of the mouse hepatitis virus ns2 phosphodiesterase domain that antagonizes RNase L activationRNase L controls terminal adipocyte differentiation, lipids storage and insulin sensitivity via CHOP10 mRNA regulationStructural insights into RNA duplexes with multiple 2΄-5΄-linkages.Endoribonuclease L (RNase L) regulates the myogenic and adipogenic potential of myogenic cellsDynamic light scattering: a practical guide and applications in biomedical sciences.2'-5'-Oligoadenylate synthetase single-nucleotide polymorphisms and haplotypes are associated with variations in immune responses to rubella vaccine.Novel host-related virulence factors are encoded by squirrelpox virus, the main causative agent of epidemic disease in red squirrels in the UK.Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons.Strand-specific (asymmetric) contribution of phosphodiester linkages on RNA polymerase II transcriptional efficiency and fidelity.Expression, purification and characterization of the interferon-inducible, antiviral and tumour-suppressor protein, human RNase L.RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP.Identification of cis- and trans-acting factors involved in the localization of MALAT-1 noncoding RNA to nuclear speckles.Uterine epithelial cells specifically induce interferon-stimulated genes in response to polyinosinic-polycytidylic acid independently of estradiol.Genetic associations in type I interferon related pathways with autoimmunityA functional Toll-like receptor 3 gene (TLR3) may be a risk factor for tick-borne encephalitis virus (TBEV) infectionOxymetholone therapy of fanconi anemia suppresses osteopontin transcription and induces hematopoietic stem cell cycling.Roles of retinoic acid-inducible gene-I-like receptors (RLRs), Toll-like receptor (TLR) 3 and 2'-5' oligoadenylate synthetase as viral recognition receptors on human mast cells in response to viral infection.Impact of template backbone heterogeneity on RNA polymerase II transcription.2'-5' oligoadenylate synthetase 1 polymorphism is associated with prostate cancerMitochondrial localization of the OAS1 p46 isoform associated with a common single nucleotide polymorphism.Enzyme assays for synthesis and degradation of 2-5As and other 2'-5' oligonucleotides.Trans-Species Polymorphism in Immune Genes: General Pattern or MHC-Restricted Phenomenon?Long-term balancing selection at the antiviral gene OAS1 in Central African chimpanzees.The contribution of rodent models to the pathological assessment of flaviviral infections of the central nervous systemSmall-interfering RNA-mediated silencing of the MAPK p42 gene induces dual effects in HeLa cells.The poxvirus C7L host range factor superfamily.Staphylococcus aureus α-toxin modulates skin host response to viral infection.Specificity protein 1 is pivotal in the skin's antiviral response.Genome-wide DNA methylation analysis in multiple tissues in primary Sjögren's syndrome reveals regulatory effects at interferon-induced genes.Impact of IL28B and OAS gene family polymorphisms on interferon treatment response in Caucasian children chronically infected with hepatitis B virus.Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways.
P2860
Q21089709-65386CE8-CF02-4F93-9637-66CF1FC2879FQ21135293-C3E53E4A-519A-4AAD-AA8A-1ACD768802A2Q24681387-C84A0763-1B2C-4B53-82E3-ED6D0DD414B1Q26772138-5626E3AA-2CA7-426C-AD59-562DC3C24073Q27016149-94214E42-7FAA-4A41-9304-BC88A034B0D6Q27026181-66C35D80-AB6D-4CCE-9CF9-26D49CC736EBQ27486790-BA694728-604E-4B06-9F3E-C377AC9BC6B3Q27487937-7C341B15-5114-4DDA-9A02-84EB49541D83Q27489370-E141B09F-F0F9-4EDF-BC05-C2A789FF4F38Q27703597-3820B67B-6FA2-4F1E-849A-71313B38A67DQ28511132-D2035DFB-9ED2-46EA-85FC-CB9362EC5B98Q30845087-7DF3E3D1-7432-4788-97AD-6A5A7E867BE4Q33511996-A6501780-FC37-4A16-8B8E-DA2F57FB460EQ33659644-C23D8A09-E685-44A7-BE3F-6E4EB0F5D49DQ33742272-F8016482-072B-485E-ABB0-44C27F4A6558Q33830482-19C324B2-C7A5-4ED2-9F8C-99FF02D76598Q33884499-29E55E42-7DA8-4FD4-A619-2EF83DA196C1Q34060596-5B00346B-8A57-46AD-8DB2-462279DBAEC5Q34167138-FAE21D8D-81BA-4642-86F4-EA40B2417CFCQ34210374-30F2C1F9-4803-472A-97E8-F060E215DBA5Q34256108-30DA6B1B-92D6-47BB-838B-BBBD3A82ED4DQ34256586-3BF4FD15-D8A8-4B37-835C-B58FD8ACFA63Q34350182-888B434B-3188-4724-93F4-AA8B0569771FQ34764439-9B1AD717-7C02-4055-B6F8-4C0A7BD999F7Q34980734-4929C179-AE6E-43AC-8601-1E229C3B590FQ35108311-C335F6E7-199D-4F71-AFC9-C48B5A13AEF8Q35131111-F16EEA59-C448-4F49-B574-E1253712659CQ35199341-BB1F3C73-9EDF-4258-A4A2-E4E4A1359203Q35245144-D82FDCAF-C998-4DAD-A1E4-758889D30652Q35675075-323FFA39-9DB5-4A51-923F-66C8BFFA04E7Q35690726-E466DC5F-E472-4600-B74A-6E4BCCD494A1Q35927003-5FA98F88-2BED-4C57-B3D8-75EE6A30163BQ36089982-F867C3B6-210F-428A-950E-D866E182B476Q36216618-B22D7D77-722D-4A83-9FBC-535FB72DF456Q36427971-9E430CB7-B221-4242-9E5A-2923E60A2516Q36676808-072875BA-4165-4B5C-9D5D-52FBEE379618Q37073740-ED6D6425-D49C-4562-BCEA-6D31976E1A21Q37398914-301AF787-47F8-4226-9938-BF8D38933F3DQ37411318-923C0D4A-8AB1-4C5B-B1BC-CDD0A3FEB094Q37564490-CF80791C-BE8A-4BEC-9066-98705EF432E9
P2860
The human 2'-5'oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2'-5' instead of 3'-5' phosphodiester bond formation.
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The human 2'-5'oligoadenylate ...... phosphodiester bond formation.
@ast
The human 2'-5'oligoadenylate ...... phosphodiester bond formation.
@en
The human 2'-5'oligoadenylate ...... phosphodiester bond formation.
@nl
type
label
The human 2'-5'oligoadenylate ...... phosphodiester bond formation.
@ast
The human 2'-5'oligoadenylate ...... phosphodiester bond formation.
@en
The human 2'-5'oligoadenylate ...... phosphodiester bond formation.
@nl
prefLabel
The human 2'-5'oligoadenylate ...... phosphodiester bond formation.
@ast
The human 2'-5'oligoadenylate ...... phosphodiester bond formation.
@en
The human 2'-5'oligoadenylate ...... phosphodiester bond formation.
@nl
P1433
P1476
The human 2'-5'oligoadenylate ...... phosphodiester bond formation.
@en
P2093
Ara G Hovanessian
Just Justesen
P304
P356
10.1016/J.BIOCHI.2007.02.003
P577
2007-02-20T00:00:00Z